LUPIN LIMITED vs MANIPAL HEALTH ENTERPRI L

A side-by-side comparison of LUPIN LIMITED (LUPIN) and MANIPAL HEALTH ENTERPRI L (MANIPALHOS) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, LUPIN LIMITED leads LUPIN vs MANIPALHOS on 14 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation40
  • Profitability40
  • Growth20
  • Size & financial health40
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

LUPIN takes 4/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

16.73
P/E ratio
178.52
4.23
P/B ratio
5.87
0.87%
Dividend yield
0.00%
₹116.75
EPS
₹3.64

Profitability

LUPIN takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

23.76%
Return on equity
8.56%
25.14%
Return on capital
10.20%
31.53%
EBITDA margin
25.00%
19.16%
Net margin
12.00%

Growth

LUPIN takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

18.88%
Revenue CAGR (3Y)
14.17%
128.65%
Profit CAGR (3Y)
30.38%

Size & financial health

LUPIN takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹89,318 Cr
Market cap
₹85,506 Cr
₹27,958 Cr
Revenue
₹3,584 Cr
₹5,355 Cr
Net profit
₹430 Cr
0.29
Debt / equity
0.48
LUPIN LIMITED
  • + ["Company has delivered good profit growth of 34.3% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 20.8%"]
  • − []
MANIPAL HEALTH ENTERPRI L
  • + ["Company has delivered good sales growth of 20.6% CAGR over last 5 years"]
  • − ["Though the company is reporting repeated profits, it is not paying out dividend"]
LUPIN LIMITED full analysis MANIPAL HEALTH ENTERPRI L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.